| Literature DB >> 35891175 |
Jennifer A Frey1,2, Daniel J Bachmann1,2, Mirela Anghelina3, Valerie Sircelj1,2, Osama Saadoon1,2, Patrick Stevens3, Maciej Pietrzak3, Soledad Fernández3,4, Ann Scheck McAlearney2,3,5,6, Ashish R Panchal1,2,5.
Abstract
(1) Background: COVID-19 vaccination status varies widely among law enforcement and emergency medical services professionals. Though at high risk of exposure, these first responders have demonstrated significant vaccine hesitancy, with only 70% reportedly vaccinated. We sought to understand whether similar vaccine hesitancy exists for first responders and their household contacts around COVID-19 boosters. (2)Entities:
Keywords: COVID-19; booster; emergency medical services; first responder; frontline healthcare workers; households; vaccination
Year: 2022 PMID: 35891175 PMCID: PMC9319131 DOI: 10.3390/vaccines10071011
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Cohort demographics by vaccination status.
| Full Cohort | Unvaccinated | Vaccinated | ||
|---|---|---|---|---|
| Age | ||||
| Median, IQR | 47 (38–52) | 38.5 (31–50.5) | 48 (41–52) | 0.002 |
| Gender ( | ||||
| Male | 76 (63.9) | 18 (58.1) | 58 (67.4) | 0.7 |
| Female | 37 (31.1) | 10 (32.3) | 27 (31.4) | |
| Unknown | 6 (5.0) | 3 (9.7) | 1 (1.2) | |
| Race ( | ||||
| White | 102 (85.7) | 24 (77.4) | 78 (90.7) | 0.4 |
| Black | 6 (5.0) | 3 (9.7) | 3 (3.5) | |
| Other | 3 (2.5) | 1 (3.2) | 2 (2.3) | |
| Asian or Pacific Islander | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| American Indian | 1 (0.8) | 0 (0.0) | 1 (1.2) | |
| Unknown | 7 (5.9) | 3 (9.7) | 2 (2.3) | |
| Previous SARS-CoV-2 infection ( | ||||
| Yes | 41 (34.5) | 13 (41.94) | 28 (32.6) | <0.001 |
| No | 45 (37.8) | 3 (9.7) | 42 (48.8) | |
| I don’t know | 26 (21.9) | 12 (38.7) | 14 (16.3) | |
| No response | 7 (5.9) | 3 (9.7) | 2 (2.3) | |
| Any Comorbidity | 48 (40.3) | 9 (29.0) | 39 (45.4) | 0.2 |
| Common Comorbidities | ||||
| Hypertension (high blood pressure) | 20 (16.8) | 2 (6.5) | 18 (21.0) | |
| Asthma | 7 (5.9) | 1 (3.2) | 6 (7.0) | |
| Other autoimmune diseases | 7 (5.9) | 1 (3.2) | 6 (7.0) | |
| Cancer—current or past | 6 (5.04) | 1 (3.2) | 5 (5.8) | |
| Inflammatory bowel disease | 5 (4.2) | 1 (3.2) | 4 (4.7) | |
| Diabetes (any type) | 3 (2.5) | 1 (3.2) | 2 (2.3) | |
| Smoking Status | ||||
| Never smoked | 103 (86.55) | 27 (87.1) | 76 (88.37) | 0.001 |
| Current or former smoker | 10 (8.4) | 1 (3.23) | 9 (10.47) | |
| Missing | 6 (5.04) | 3 (9.68) | 1 (1.16) |
Vaccination information for the complete cohort (n = 119).
| Vaccine Information | |
|---|---|
| Vaccination | |
| Unvaccinated | 31 (26.1) |
| Partial primary COVID-19 vaccine | 8 (6.72) |
| Full primary COVID-19 vaccine | 51 (42.9) |
| Full primary COVID-19 vaccine plus booster | 27 (22.7) |
| Unknown | 2 (1.7) |
| Type of Vaccination | |
| Moderna (2 dose for full primary vaccination) | 44 (51.2) |
| BioNTech, Pfizer (2 dose for full primary vaccination) | 36 (41.9) |
| AstraZeneca (2 dose for full primary vaccination) | 1 (1.2) |
| Johnson and Johnson (1 dose for full primary vaccination) | 5 (5.8) |
Figure 1Agreement within households was different for receiving primary COVID-19 vaccinations and boosters (p < 0.005). Agreement for primary vaccination was high (60%), whereas agreement for boosters was low (20%) within households.